HLA-G Gene Polymorphism in Egyptian Patients with Non-Hodgkin Lymphoma and its Clinical Outcome

References

• Beral P , Berkelman R , Jaffe H. (1991). AIDS-associated non-Hodgkin lymphoma. The Lancet, 337, 805–809. doi: 10.1016/0140-6736(91)92513-2.
   PubMed Web of Science ®Google Scholar
• Bielska M , Bojo M , Klimkiewicz-Wojciechowska G , et al. (2015). Human Leukocyte Antigen-G Polymorphisms Influence the Clinical Outcome in Diffuse Large B-Cell Lymphoma. Genes Chromosomes Cancer, 54. 185–193.
   PubMed Web of Science ®Google Scholar
• Cai M , Han H , Bei J , et al. (2012). Expression of human leukocyte antigen G is associated with prognosis in nasopharyngeal carcinoma. IntJBiolSci, 8. 891–900.
   Google Scholar
• Cao M , Yie S , Liu J , et al. (2011). Gao E Plasma soluble HLA-G is a potential biomarker for diagnosis of colorectal, gastric, esophageal and lung cancer. Tissue Antigens, 78. 120–128.
   PubMed Web of Science ®Google Scholar
• Carosella E , Horuzsko A. (2007). HLA-G and cancer. Sem Cancer biol, 17. 411–421.
   PubMed Web of Science ®Google Scholar
• Chen H , Lin A , Shen C , et al. (2010). Up regulation of humanleukocyteantigen-Gexpressionanditsclinicalsignificanceinduc-tal breast cancer. Hum Immunol, 71. 892–898.
   PubMed Web of Science ®Google Scholar
• Chodon T , Koya RC , Odunsi K , et al. (2015). Active Immunotherapy of Cancer. Immunol Invest. 44. 817–836.
   Google Scholar
• Dardano A , Rizzo R , Polini A , et al. (2012). Soluble human leukocyte antigen-g and its insertion/deletion polymorphism in papil- lary thyroid carcinoma: novel potential biomarkers of disease?. J ClinEndocrinolMetab, 97. 4080–4086.
   PubMed Web of Science ®Google Scholar
• Donadi A , Castelli E , Arnaiz-Villena A , et al. (2011). “Implications of the polymorphism of HLA-G on its function, regulation, evolution and disease association,”. Cellular and Molecular Life Sciences, 68. 369–395.
   PubMed Web of Science ®Google Scholar
• Du L , Xiao X , Wang C , et al. (2011). Human leukocyte antigen-G is closely associated with tumor immune escape in gastric can- cer by increasing local regulatory T cells. Cancer Sci, 102. 1272–1280.
   PubMed Web of Science ®Google Scholar
• El Bolkainy M , Nouh M , Farahat . (2013). Epidemiology of cancer. Pathology of Cancer. Vol. chapter 2. 15–31. Cairo Press: Cairo, Egypt. 4th.
   Google Scholar
• Eskandari-Nasab E , Hashemi M , Hasani S , Omrani M. (2013). Taheri M and Mashhadi M. Association between HLA-G 3ʹUTR 14-bp ins/del polymorphism and susceptibility to breast cancer. Cancer Biomarkers, 13. 253–259.
   PubMed Web of Science ®Google Scholar
• Filipovich A , Mathur A , Kamat D , Shapiro R. (1992). Primary immunodeficiencies: genetic risk factors for lymphoma. Cancer Res, 52. 5465s–67s.
   PubMed Web of Science ®Google Scholar
• Gan L , Huang L , Zhang X , et al. (2010). Tumor-specific upregulation of human leukocyte antigen-G expression in bladder transitional cell carcinoma. HumImmunol, 71. 899–904.
   Web of Science ®Google Scholar
• González A , Rebmann V , LeMaoult J , Horn P . (2012). Carosella E and Alegre E. The immunosuppressive molecule HLA-G and its clinical implications. Crit Rev Clin Lab Sci, 49. 63–84.
   PubMed Web of Science ®Google Scholar
• Gregori S , Tomasoni D , Pacciani V , et al. (2010). Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathway. Blood, 116. 935–944.
   PubMed Web of Science ®Google Scholar
• Hashemi M , Eskandari-Nasab E , Fazaeli A , et al. (2012). Bi-directional PCR allele-specific amplification (bi-PASA) for detection of caspase-8-652 6N ins/del promoter polymorphism (rs3834129) in breast cancer. Gene, 505. 176–179.
   PubMed Web of Science ®Google Scholar
• He X , Dong D , Yie S , et al. (2010). HLA-G expression in human breast cancer: implications for diagnosis and prognosis, and effect on allo-cytotoxic lymphocyte response after hormone treatment in-vitro. Ann SurgOncol, 17. 1459–1469.
   Google Scholar
• Jasinski-Bergner S , Reches A , Stoehr C , et al. (2016). Identification of novel microRNAs regulating HLAG expression and investigating their clinicalrelevance in renal cell carcinoma. Oncotarget, 7. 26866–26878.
   PubMedGoogle Scholar
• Jeong S , Park S , Park B , et al. (2014). Kim H Human Leukocyte Antigen-G (HLA-G) Polymorphism and Expression in Breast Cancer Patients. PLoS ONE, 9. e98284.
   PubMed Web of Science ®Google Scholar
• Jiang Y , Chen S , Jia S , et al. (2011). AssociationofHLA-G3ʹ UTR 14-bpinsertion/deletion polymorphism with hepatocellular carcinoma susceptibility in a Chinese population. DNA Cell Biol, 30. 1027–1032.
   PubMed Web of Science ®Google Scholar
• Kim S , Chung J , Jeon J , et al. (2013). Association between HLA-G 14-bp insertion/deletion polymorphism and hepatocellular carcinoma in Korean patients with chronic hepatitis B viral infection. Hepato Gastroenterology, 60. 796–798.
   PubMedGoogle Scholar
• Kren L , Valkovs K , Doleze L , et al. (2012). HLA-G and HLA-E specific mRNAs con not eopposite prognostic significance in renal cell carcinoma. DiagnPathol, 7. 58.
   Google Scholar
• Landgren O , Engels E , Pfeiffer R , et al. (2006). Autoimmunity and susceptibility to Hodgkin lymphoma: a population-based case-control study in Scandinavia. J Natl Cancer Inst, 9. 1321–1330.
   Google Scholar
• Lau D , Norris M , Marshall G , et al. (2011). polymorphisms, genetic susceptibility, and clinical outcome in childhood neurob- lastoma. Tissue Antigens, 78. 421–427.
   PubMedGoogle Scholar
• Liang S , Ristich V , Arase H , et al. (2008). of dendritic cell differentiation by HLA-G and ILT4 requires the IL-6–STAT3 signaling pathway. Proc Natl Acad Sci U S A, 105, 8357–8362.
   PubMed Web of Science ®Google Scholar
• Lin A , Chen H , Zhu C , et al. (2010). Aberrant human leukocyte antigen-G expression and its clinical relevance in hepato cellularcar- cinoma. J CellMolMed, 14. 2162–2171.
   Google Scholar
• Lin A , Xu H , Xu D , et al. (2013). Multiple steps of HLA-G in ovarian carcinoma metastasis: alter NK cytotoxicity and induce matrix metalloproteinase-15 (MMP-15) expression. Hum Immunol, 74. 439–446.
   PubMed Web of Science ®Google Scholar
• Morandi F . (2014). Rouas-Freiss N and Pistoia V. The emerging role of soluble HLA-G in the control of chemotaxis. Cytokine Growth Factor Rev, 25. 327–335.
   PubMed Web of Science ®Google Scholar
• Neri A , Barriga F , Inghirami G , et al. (1991). Epstein-Barr virus infection precedes clonal expansion in Burkitt’s and acquired immunodeficiency syndrome-associated lymphoma. Blood, 77. 1092–1095.
   PubMed Web of Science ®Google Scholar
• Park Y , Park Y , Lim H , Kim Y . Hong D and Kim H . (2012). Soluble human leukocyte antigen-G expression in hepatitis B virus infection and hepatocellular carcinoma. Tissue Antigens, 79. 97–103.
   PubMedGoogle Scholar
• Parsonnet J , Hansen S , Rodriguez L , et al. (1994). Helicobacter pylori infection and gastric lymphoma. N Engl J Med, 330. 1267–1271.
   PubMed Web of Science ®Google Scholar
• Provatopoulou X , Kalogera E , Sagkriotis A , et al. (2012). Soluble human leukocyte antigen-G expression in patients with ductal and lobular breast malignancy. Anticancer Res, 32. 1021–1026.
   PubMed Web of Science ®Google Scholar
• Ramos C , Goncalves A , Marinho L , et al. (2014). Analysis of HLA-G gene polymorphism and protein expression in invasive breastductal carcinoma. HumImmunol, 75. 667–672.
   Web of Science ®Google Scholar
• Rizzo R , Audrito V , Vacca P , et al. (2014). HLA-G is a component of the chronic lymphocytic leukemia escape repertoire to generate immune suppression: impact of the HLA-G 14 base pair (rs66554220) polymorphism. Haematologica, 99. 888–896.
   PubMed Web of Science ®Google Scholar
• Rm T , Abdel-Aziz AM , El-Maadawy EA , Abdel-Bary N . (2015). CD38 and interleukin 6 gene polymorphism in Egyptians with diffuse large B-cell lymphoma (DLBCL). Immunol Invest, 44. 265–278.
   PubMed Web of Science ®Google Scholar
• Sabattini E , Bacci F , Sagramoso C , Pileri S . (2010). WHO classification of tumours of haematopoietic and lymphoid tissues in 2008: an overview. Pathologica, 102. 83–87.
   PubMedGoogle Scholar
• Sayed D , Badr G , Maximous D , et al. (2010). HLA-Gand its relation to proliferation index in detection and monitoring breast cancer patients. Tissue Antigens, 75. 40–47.
   PubMedGoogle Scholar
• Shiroishi M , Kuroki K , Ose T , et al. (2006). Efficient leukocyte Ig like receptor signaling and crystal structure of disulfide-linked HLA-G dimer. Journal of Biological Chemistry, 281. 10439–10447.
   PubMed Web of Science ®Google Scholar
• Swets M , Seneby L , Boot A , et al. (2016). Promoter methylation and mRNA expression of HLA-G in relation to HLA-G protein expression in colorectal cancer. HumImmunol, 77. 764–772.
   Web of Science ®Google Scholar
• Tripathi P , Agrawal S. (2006). Non-classical HLA-G antigen and its role in the cancer progression. Cancer invest, 24. 178–186.
   PubMed Web of Science ®Google Scholar
• Tunce T , Karagoz B , Haholu A , et al. (2013). Immuno regulatory function of HLA-G in gastric cancer. Asian Pac J Cancer Prev, 14. 7681–7684.
   PubMedGoogle Scholar
• Wang Y , Ye Z , Meng X , Zheng S . (2011). Expression of HLA-G in patients with hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int, 10. 158–163.
   PubMed Web of Science ®Google Scholar
• Yan W . (2011). Human leukocyte antigen-G in cancer: are they clinically relevant?. Cancer Lett. 311. 123–130.
   Google Scholar
• Zheng J , Xu C , Chu D , et al. (2014). Human leukocyte antigen G is associated with esophageal squamous cell carcinoma progression and poor prognosis. ImmunolLett, 161. 13–19.
   Web of Science ®Google Scholar